A Prospective, Non-Interventional, Post-Marketing Observational Study Evaluating the Effectiveness and Safety of Selpercatinib Capsules in Adults and Pediatric Patients with Advanced or Metastatic RET Fusion-Positive Thyroid Cancer First published 12/06/2023 Last updated 19/03/2024 EU PAS number:EUPAS105321 Study Planned